Investment
Features
FeesSafety
Academy
More
Pluang+

RenaissanceRe posts strong underwriting and net income, boosts share buybacks, and offers attractive preferred shares yield.

Market News
17 Oct 2026
Seeking Alpha
View Source
Bullish
RenaissanceRe posts strong underwriting and net income, boosts share buybacks, and offers attractive preferred shares yield.

RenaissanceRe Holdings (RNR), a major reinsurance company, reported a strong underwriting performance with a combined ratio of 72.8% and solid net income, benefiting both common and preferred shareholders. The company aggressively repurchased shares, spending over $700 million in the first half of the year and maintaining a $557 million buyback authorization, which supports book value per share growth. Its Series G preferred shares offer a 7.3% yield with a low 4.2% coupon, making them attractive in the current interest rate environment. The investment outlook favors a mix of common and preferred shares due to management's focus on capital return and book value growth.

RenaissanceRe Holdings preferred stock is the subject, with Pluang's Financials-sector snapshot providing market context. Of 142 priced Financials-sector US stocks on Pluang, 63 advanced and 78 declined today. Notable movers include CRCL at USD 82.22 with a 5.46% drop, OXLC priced at USD 7.91 down 5.38%, and HOOD at USD 98.87 falling 4.92%, as of Oct 17, 2026 19:11 WIB.

More News

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

Ascendis Pharma announced that the European Medicines Agency's CHMP has given a positive opinion for TransCon CNP (Navepegritid), a once-weekly treatment for achondroplasia in children aged 2 and above with open growth plates. This recommendation sup...

Market News
Bullish
2 hours ago
EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...

Market News
Bullish
2 hours ago
US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

Morgan Stanley reports a 32-gigawatt electricity deficit for US data centers through 2028, a 34% shortfall even after alternative power sources. This power gap threatens AI growth as data centers need constant energy to operate. Tech analyst James Al...

Market News
Neutral
2 hours ago
Arthur Hayes' fund trades altcoins mainly to buy more Bitcoin, aiming to accumulate BTC despite altcoin disappointments.

Arthur Hayes' fund trades altcoins mainly to buy more Bitcoin, aiming to accumulate BTC despite altcoin disappointments.

Arthur Hayes, CIO of Maelstrom and co-founder of BitMEX, revealed that his fund trades altcoins primarily to generate profits for purchasing additional Bitcoin. He expressed disappointment with altcoins' performance in recent years but continues to f...

Market News
Neutral
4 hours ago
Hashi coalition commits $500M to Sui protocol ahead of phased mainnet launch in October

Hashi coalition commits $500M to Sui protocol ahead of phased mainnet launch in October

Hashi's coalition, consisting of over 20 partners, has committed more than $500 million to support the Sui-based protocol as it prepares for a phased mainnet rollout planned for later in October. Users send Bitcoin to addresses managed by Hashi, whic...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App